Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy-Reference-Cited by-同舟云学术

Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy

Published:2022-12-20 Issue:6 Volume:14 Page:139-148
ISSN:2310-1342
Container-title:Neurology, Neuropsychiatry, Psychosomatics
language:
Short-container-title:RJTAO

Author:

Krasnov V. S.¹^ORCID,Bakhtiyarova K. Z.²^ORCID,Evdoshenko E. P.³^ORCID,Korobko D. S.⁴^ORCID,Simaniv T. O.⁵^ORCID,Totolyan N. A.¹^ORCID,Khachanova N. V.⁶^ORCID,Shumilina M. V.⁷^ORCID,Davydovskaya M. V.⁸^ORCID

Affiliation:

1. Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

2. Bashkir State Medical University, Ministry of Health of Russia

3. City Center for Multiple Sclerosis, City Clinical Hospital Thirty-One

4. Regional Center of Multiple Sclerosis and other Autoimmune Diseases of Nervous system, Novosibirsk State Regional Clinical Hospital; Novosibirsk State Medical University, Ministry of Health of Russia

5. Research Center of Neurology

6. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Interdistrict Department of Multiple Sclerosis, City Clinical Hospital No 24, Moscow Healthcare Department

7. Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia; City Center for Multiple Sclerosis, City Clinical Hospital Thirty-One

8. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Research and Practical Center for Clinical and Economic Analysis, Ministry of Health of the Moscow Region

Publisher

IMA Press, LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Clinical Psychology

Reference59 articles.

1. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89. doi:10.1212/WNL.0000000000001729

2. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep;6(9):805-15. doi:10.1016/S1474-4422(07)70216-8

3. Ma X, Kermode AG, Hu X, Qiu W. NMOSD acute attack: Understanding, treatment and innovative treatment prospect. J Neuroimmunol. 2020 Nov 15;348:577387. doi:10.1016/j.jneuroim.2020.577387

4. Starodubov VI, Zelenova OV, Abramov SI, et al. The first observational epidemiological study to determine the incidence and prevalence of disease range of neuromyelitis optica (Devik’s disease) on the territory of the Russian Federation. Sovremennye problem zdravookhraneniya i meditsinskoi statistiki = Current Problems of Health Care and Medical Statistics. 2021;(1):130-41. doi:10.24411/2312-2935-2021-00007 (In Russ.).

5. Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017 Apr;92(4):663-79. doi:10.1016/j.mayocp.2016.12.014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience of using eculizumab in refractory myasthenia gravis;S.S. Korsakov Journal of Neurology and Psychiatry;2024

2. Neuromyelitis optica spectrum disorders and complement system: issues of pathogenesis and therapeutic options;Neurology, Neuropsychiatry, Psychosomatics;2023-12-17

3. Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy;Neurology, Neuropsychiatry, Psychosomatics;2023-08-21

4. Delayed diagnosis of the neuromyelitis optica spectrum disorder;Neurology, Neuropsychiatry, Psychosomatics;2023-08-21

5. Comments on the article “Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy”;Neurology, Neuropsychiatry, Psychosomatics;2023-02-19